Evaluation of the effect of dry needling of scapular and shoulder muscles painful points on pain and function of patients with carpal tunnel syndrome

Not Applicable

Recruiting

Conditions: Carpal tunnel syndrome.
Carpal tunnel syndrome
G56.0

Registration Number: IRCT20220530055032N1

Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 40

Inclusion Criteria

Patients with mild to moderate carpal tunnel syndrome
Aged between 30 and 60 years
Pain and paresthesia in hand (especially thumb, index and middle fingers)
Having symptoms for more than one month
Positive Phalen’s test
Positive Tinel’s test
Painful myofascial points at least in two muscles around scapula (Upper Trapezius, Supraspinatus, Infraspinatus, Subscapularis, Teres minor and major) and at least in one muscle around shoulder (Biceps and Deltoid)
Normal BMI to overweight

Exclusion Criteria

Cervical disc protrusion
Cervical radiculopathy
Cervical vertebral degeneration
Double crush syndrome
Upper limb fracture
Sensory or motor defects of the ulnar or radial nerves
History of wrist or cervical spine severe injury
Previous wrist, upper limb or cervical vertebrae surgeries
History of steroid injection into the wrist
History of systemic disease causing carpal tunnel syndrome such as diabetes, rheumatoid arthritis and fibromyalgia
Pregnancy
Thenar muscles atrophy
Use of blood thinner drugs
Tumor
Epilepsy

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Visual analogue scale.;Grip power. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Hand-held dynamometer.;Functional disability. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: DASH questionnaire.;Severity and functional ability. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Boston questioner.;Two point discrimination. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Two point discriminator.

Secondary Outcome Measures